June 2016

Features

Answers to the Three Big Questions of Long-Term Treatment of Wet AMD

Anti-VEGF agents have forced us to choose an agent and regimen, and learn when enough is enough.

DRCRnet Protocol T 2-year Data: Where Do We Go From Here?

Giving us clarity on the use of PRP and anti-VEGF in high-risk PDR.

Retina Report from ARVO 2016

A closer look at five abstracts on VMT, DME, AMD, OCT and gene therapy.

TAE for Wet AMD: Practical Tips from the Pros

A conversation on the nuances of implementing treat and extend.

Tips for Sutureless Scleral Fixation

A close look at two approaches to make it work for you.

Departments

Clinical Trial Closeup

APL-2’s Role in Blocking the GA Cascade

By inhibiting complement factor C3, Apellis bets it can prevent inflammation in advanced dry AMD

Coding Commentary

Editor's Page

Innovation Insight

Finding More Uses for OCT Angiography

ARVO studies compared OCTA against more invasive imaging, and one even compared OCTA in swept-source vs. spectral-domain platforms.

Medical Retina Fellows Forum

Zika Virus and the Eye

A look at the evidence on the ocular effects of this mosquito-borne outbreak.

News

Retina CEO

Is a Billing Service the Right Move?

It’s a way to outsource accounts receivable management, but it’s not the right decision for every practice.

Retina Rounds

TB or Not TB? That Is the Question

Did a complex interplay between TB and high myopia create a unique clinical entity?

Surgical Pearl Video

Tips for Sutureless Scleral Fixation

A close look at two approaches to make it work for you.